242 related articles for article (PubMed ID: 9476799)
1. A pteridine reductase gene ptr1 contiguous to a P-glycoprotein confers resistance to antifolates in Trypanosoma cruzi.
Robello C; Navarro P; Castanys S; Gamarro F
Mol Biochem Parasitol; 1997 Dec; 90(2):525-35. PubMed ID: 9476799
[TBL] [Abstract][Full Text] [Related]
2. Molecular characterization of a P-glycoprotein-related tcpgp2 gene in Trypanosoma cruzi.
Dallagiovanna B; Gamarro F; Castanys S
Mol Biochem Parasitol; 1996 Jan; 75(2):145-57. PubMed ID: 8992313
[TBL] [Abstract][Full Text] [Related]
3. Discovery of potent pteridine reductase inhibitors to guide antiparasite drug development.
Cavazzuti A; Paglietti G; Hunter WN; Gamarro F; Piras S; Loriga M; Allecca S; Corona P; McLuskey K; Tulloch L; Gibellini F; Ferrari S; Costi MP
Proc Natl Acad Sci U S A; 2008 Feb; 105(5):1448-53. PubMed ID: 18245389
[TBL] [Abstract][Full Text] [Related]
4. The roles of pteridine reductase 1 and dihydrofolate reductase-thymidylate synthase in pteridine metabolism in the protozoan parasite Leishmania major.
Nare B; Hardy LW; Beverley SM
J Biol Chem; 1997 May; 272(21):13883-91. PubMed ID: 9153248
[TBL] [Abstract][Full Text] [Related]
5. Mutant PTR1 proteins from Leishmania tarentolae: comparative kinetic properties and active-site labeling.
Chang CF; Bray T; Whiteley JM
Arch Biochem Biophys; 1999 Aug; 368(1):161-71. PubMed ID: 10415124
[TBL] [Abstract][Full Text] [Related]
6. Crystal structure of Trypanosoma cruzi pteridine reductase 2 in complex with a substrate and an inhibitor.
Schormann N; Pal B; Senkovich O; Carson M; Howard A; Smith C; Delucas L; Chattopadhyay D
J Struct Biol; 2005 Oct; 152(1):64-75. PubMed ID: 16168672
[TBL] [Abstract][Full Text] [Related]
7. Role of the locus and of the resistance gene on gene amplification frequency in methotrexate resistant Leishmania tarentolae.
Kündig C; Leblanc E; Papadopoulou B; Ouellette M
Nucleic Acids Res; 1999 Sep; 27(18):3653-9. PubMed ID: 10471733
[TBL] [Abstract][Full Text] [Related]
8. Biochemical and genetic tests for inhibitors of Leishmania pteridine pathways.
Hardy LW; Matthews W; Nare B; Beverley SM
Exp Parasitol; 1997 Nov; 87(3):157-69. PubMed ID: 9371081
[TBL] [Abstract][Full Text] [Related]
9. PTR1: a reductase mediating salvage of oxidized pteridines and methotrexate resistance in the protozoan parasite Leishmania major.
Bello AR; Nare B; Freedman D; Hardy L; Beverley SM
Proc Natl Acad Sci U S A; 1994 Nov; 91(24):11442-6. PubMed ID: 7972081
[TBL] [Abstract][Full Text] [Related]
10. New approaches to Leishmania chemotherapy: pteridine reductase 1 (PTR1) as a target and modulator of antifolate sensitivity.
Nare B; Luba J; Hardy LW; Beverley S
Parasitology; 1997; 114 Suppl():S101-10. PubMed ID: 9309772
[TBL] [Abstract][Full Text] [Related]
11. Molecular cloning, expression and enzymatic assay of pteridine reductase 1 from Iranian lizard Leishmania.
Kazemi B; Tohidi F; Bandehpour M; Yarian F
Iran Biomed J; 2010 Jul; 14(3):97-102. PubMed ID: 21079660
[TBL] [Abstract][Full Text] [Related]
12. Structure of pteridine reductase (PTR1) from Leishmania tarentolae.
Zhao H; Bray T; Ouellette M; Zhao M; Ferre RA; Matthews D; Whiteley JM; Varughese KI
Acta Crystallogr D Biol Crystallogr; 2003 Sep; 59(Pt 9):1539-44. PubMed ID: 12925782
[TBL] [Abstract][Full Text] [Related]
13. Structure and reactivity of Trypanosoma brucei pteridine reductase: inhibition by the archetypal antifolate methotrexate.
Dawson A; Gibellini F; Sienkiewicz N; Tulloch LB; Fyfe PK; McLuskey K; Fairlamb AH; Hunter WN
Mol Microbiol; 2006 Sep; 61(6):1457-68. PubMed ID: 16968221
[TBL] [Abstract][Full Text] [Related]
14. A new member of YER057c family in Trypanosoma cruzi is adjacent to an ABC-transporter.
Robello C; Dallagiovanna B; Engel JC; Gamarro F; Castanys S
Gene; 1998 Oct; 220(1-2):1-12. PubMed ID: 9767076
[TBL] [Abstract][Full Text] [Related]
15. Residues involved in co-factor and substrate binding of the short-chain dehydrogenase/reductase PTR1 producing methotrexate resistance in Leishmania.
Leblanc E; Papadopoulou B; Bernatchez C; Ouellette M
Eur J Biochem; 1998 Feb; 251(3):768-74. PubMed ID: 9490050
[TBL] [Abstract][Full Text] [Related]
16. Pteridine salvage throughout the Leishmania infectious cycle: implications for antifolate chemotherapy.
Cunningham ML; Beverley SM
Mol Biochem Parasitol; 2001 Apr; 113(2):199-213. PubMed ID: 11295174
[TBL] [Abstract][Full Text] [Related]
17. Dissecting the metabolic roles of pteridine reductase 1 in Trypanosoma brucei and Leishmania major.
Ong HB; Sienkiewicz N; Wyllie S; Fairlamb AH
J Biol Chem; 2011 Mar; 286(12):10429-38. PubMed ID: 21239486
[TBL] [Abstract][Full Text] [Related]
18. Molecular characterization and functional analysis of pteridine reductase in wild-type and antimony-resistant Leishmania lines.
de Souza Moreira D; Ferreira RF; Murta SM
Exp Parasitol; 2016 Jan; 160():60-6. PubMed ID: 26689884
[TBL] [Abstract][Full Text] [Related]
19. Molecular characterization of lipoamide dehydrogenase gene in Trypanosoma cruzi populations susceptible and resistant to benznidazole.
Dos Santos PF; Moreira DS; Baba EH; Volpe CMO; Ruiz JC; Romanha AJ; Murta SMF
Exp Parasitol; 2016 Nov; 170():1-9. PubMed ID: 27567984
[TBL] [Abstract][Full Text] [Related]
20. ABCG-like transporter of Trypanosoma cruzi involved in benznidazole resistance: gene polymorphisms disclose inter-strain intragenic recombination in hybrid isolates.
Franco J; Ferreira RC; Ienne S; Zingales B
Infect Genet Evol; 2015 Apr; 31():198-208. PubMed ID: 25660041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
